Foreign-invested hospitals make impressive gains

Driven by growth momentum, foreign-invested hospitals are planning future strategies to drive higher growth phase.

- By Bich Thuy

According to Thomson Medical Group’s (TMG) latest financial report released in late May, the Vietnamese market can contribute 25 per cent to the parent group’s total revenue during the 2025-2026 period after the acquisition of FV Hospital in 2023, making Vietnam a key market for TMG.

In the first half of the 2026 fiscal year, FV’s operations in Vietnam generated $39.88 million in revenue and $6.45 million in earnings before interest, taxes, depreciation, and amortisation.

Ng Ser Miang, chairman of the board at TMG, said, “We remain confident in the potential of FV Hospital as well as Vietnam’s economic and demographic foundations. Continued investment in expanding the hospital is part of our long-term thesis: Vietnam will be one of Southeast Asia’s most important healthcare growth markets, and FV Hospital is well-positioned to become a trusted provider of international standard services.”

After the deal, TMG continues to invest in the local market. Last May, FV Hospital disbursed nearly $8 million for the CyberKnife S7 robotic system for non-invasive treatment of systemic tumours. This technology complex, along with the in-vitro fertilisation centre and the advanced dialysis unit, will be located in a new building and is expected to officially begin operations at the end of 2027 to capitalise on the growing wave of medical tourism.